UC San Diego School of Medicine Names New Division Chief for Gastroenterology

 

August 23, 2010  |  

William Sandborn, MD, has been named the Division Chief for Gastroenterology in the University of California, San Diego Department of Medicine pending UCSD campus approval of his faculty appointment.  Currently Vice Chair of the Division of Gastroenterology and Hepatology at the Mayo Clinic in Rochester, Minnesota, Sandborn is expected to begin at UC San Diego School of Medicine at the end of the year.

William Sanborn

William Sandborn, MD

After medical school and an internal medicine residency at Loma Linda University, Sandborn completed a gastroenterology fellowship at the Mayo Clinic in 1993. In addition to serving as vice chair, he is the Dorothy A. Adair Professor of Medicine at Mayo Clinic College of Medicine and Associate Dean of Research for Intellectual Property and Industry Relations at Mayo Clinic. 

Sandborn has published more 340 peer reviewed articles, including articles in the New England Journal of Medicine, The Lancet, JAMA, The Annals of Internal Medicine, and the journal Gastroenterology. His research interests are clinical trials and clinical pharmacology related to inflammatory bowel disease. He is a key thought leader in the treatment of inflammatory bowel disease and has a large clinical practice in patients with these challenging illnesses.

# #  # 

Media Contact: Debra Kain, 619-543-6163, ddkain@ucsd.edu


Related Specialties

Gastroenterology



Media Contact

Share This Article


Related News

6/27/2017
Researchers at University of California San Diego School of Medicine, with colleagues in Xijing Hospital and Sun Yat-sen Cancer Center in China, report that DNA methylation can provide effective marke ...
6/15/2017
NASA has selected Alan Hargens, PhD, professor of orthopedic surgery at UC San Diego School of Medicine, to receive a 2017 Distinguished Public Service Medal.
6/15/2017
University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnso ...
6/9/2017
Radiation therapy (RT) using high-energy particles is a common and critical component in successfully treating patients with brain tumors but it is also associated with significant adverse effects. In ...



Follow Us